|
Session 107
Poster Abstracts
Epidemiology and Transmission of Resistance
Wednesday, 1:30 - 3:30 pm
Poster Hall |
| 642 |
Sensitive Drug-resistance Testing Reveals a Greater Prevalence of Transmitted Multi-drug-resistant HIV-1 than Previously Estimated
Jeffrey Johnson*1, J F Li1, A Brant1, D Bennett1, M E Cong1, T Spira1, P Sandstrom2, and W Heneine1
1CDC, Atlanta, GA, US and 2Ctr for Infectious Disease Prevention and Control, Ontario, Canada |
| 643 |
Consecutive Transmission of Dual-class Resistant HIV-1 in Untreated Patients
Kristel Van Laethem*, Y Schrooten, P Lemey, K Deforche, M Van Ranst, E Van Wijngaerden, and A M Vandamme
Katholieke Univ Leuven and Univ Hosp, Belgium |
| 644 |
Mechanisms of Acquisition of ART Drug-resistant Virus in HIV-1-infected Newborns in the French Perinatal Cohort (EPF-ANRS)
Constance Delaugerre*1, D Cornet1, M L Chaix1, J Warszawski2, C Dollfus3, M Burgard1, L Mandelbrot4, R Tubiana5, S Blanche1, and C Rouzioux1
1Necker hosp, Paris, France; 2INSERM U569, Bicetre Hosp, Le Kremlin-Bicêtre, France; 3Trousseau Hosp, Paris, France; 4Louis Mourier Hosp, Colombes, France; and 5Hosp Pitié-Salpétrière, Paris, France |
| 645 |
HIV-1 Protease and Reverse Transcriptase Mutations for HIV Drug Resistance Epidemiology and Surveillance
Diane Bennett*1, S Y Rhee2, D Pillay3, V Miller4, P Sandstrom5, J Schapiro6, D Kuritzkes7, and R Shafer2
1World Hlth Org, Geneva, Switzerland; 2Stanford Univ, CA, US; 3Univ Coll, London, UK; 4Forum for Collaborative HIV Res, George Washington Univ, Washington, DC, US; 5Publ Hlth Agency of Canada, Ottawa; 6Natl Hemophilia Ctr, Sheba Med Ctr, Tel Hashomer, Israel; and 7Brigham and Women's Hosp, Harvard Med Sch, Boston, MA, US |
646
 |
Current Trends in HIV Molecular Epidemiology in Canada
Results of the National Surveillance Program
Richard Pilon*1, J Brooks1, N Goedhuis2, G Jayaraman2, C Archibald2, and P Sandstrom1
1Natl HIV and Retrovirology Labs and 2Surveillance and Risk Assesment Div |
| 647 |
Multi-center Nationwide Survey of Drug-resistant HIV-1 in Newly Diagnosed HIV/AIDS Patients in Japan from 2003 to 2004
H Gatanaga1, T Koike2, T Asagi3, H Tsukada4, M Kondo5, A Masakane6, T Kaneda7, H Mori8, R Minami9, Wataru Sugiura*10, and Japanese Drug Resistance HIV-1 Surveillance Network
1Intl Med Ctr, Toyama, Japan; 2Hokkaido Univ Sch of Med, Japan; 3Sendai Med Ctr, Japan; 4Niigata Univ Graduate Sch of Med and Dental Sci, Japan; 5Kanagawa Prefectural Inst of Publ Hlth, Japan; 6Ishikawa Prefectural Central Hosp, Japan; 7Nagoya Med Ctr, Japan; 8Osaka Prefectural Inst of Publ Hlth, Japan; 9Kyusyu Med Ctr, Japan; and 10NIAID, NIH, DHHS, Bethesda, MD, US |
648
|
Prevalence of Resistance to at Least 1 Drug in Treated HIV-infected Patients with Viral Load >1000 Copies/mL in 2004: A French Nationwide Study
Dominique Costagliola*1, L Morand-Joubert2, L Assoumou1, V Brodard3, J C Plantier4, C Delaugerre5, V Mackiewicz6, S Saidi1, F Brun-Vezinet7, B Masquelier8, and the ANRS AC11 Resistance Study Group
1U720 INSERM and Univ Pierre et Marie Curie, Paris, France; 2Hosp St Antoine, Paris, France; 3Univ Hosp, Reims, France; 4Univ Hosp, Rouen, France; 5Necker Univ Hosp, Paris, France; 6Univ Hosp Paul Brousse, Villejuif, France; 7Hosp Bichat, Paris, France; and 8Univ Hosp Bordeaux, France |
649
|
Projection to 2010 of Trends in Multi-drug-resistant HIV in Infectious Gay Men
Andrew N. Phillips
Royal Free and Univ Coll Med Sch, London, UK |
|
